Fresh from launching its array-based Prove-it Herpes diagnostic last week, Finnish molecular diagnostics firm Mobidiag said it plans to develop similar tests for sepsis and multiple bacterial infections.
 
The company said Prove-it Herpes, which tests for eight different human herpes viruses in a single sample, may eventually replace the slower, PCR-based assays currently used in European clinical labs and hospitals. These assays test for a single human herpes virus at a time.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.